What is BHRT and how do I know if I need it?

Short answer

• BHRT = bioidentical hormone replacement therapy. It uses hormones that are chemically identical to the hormones your body makes (estradiol, progesterone, testosterone) to treat symptoms of hormone deficiency (most commonly menopausal or low‑testosterone symptoms).
• Whether you “need” it depends on your symptoms, medical history and risk factors. See a clinician to review symptoms, run appropriate tests, and discuss risks and alternatives.

What BHRT is (brief)

• “Bioidentical” means the molecular structure matches human hormones (e.g., 17β‑estradiol, micronized progesterone).
• BHRT can be delivered as FDA‑approved products (transdermal estradiol patches, oral micronized progesterone) or as compounded formulations made by pharmacies to individualized doses and combinations.
• Forms: pills, patches, topical gels/creams, vaginal rings/creams, injections, and subcutaneous pellets.

How BHRT differs from conventional HRT

• Many conventional prescription products (for example, estradiol patches or micronized progesterone) are already bioidentical. The main difference people cite is compounded BHRT, which is customized but is not FDA‑tested for safety/consistency.
• Transdermal estradiol (patch/gel) avoids first‑pass liver metabolism and is generally associated with lower risk of certain clotting problems compared with oral estrogen.

Who might be a candidate

• Typical candidates:
  • Women with bothersome menopausal symptoms (hot flashes, night sweats, sleep disturbance, severe mood changes, vaginal dryness, painful intercourse) that affect quality of life.
  • Women with premature ovarian insufficiency or surgical menopause.
  • Men with clinically low testosterone documented by symptoms + laboratory evidence.
• Factors that influence the decision: age, time since menopause, personal/family history of breast cancer, blood clots, stroke, heart disease, liver disease, and smoking.

What tests and evaluation are commonly used

• Thorough history and physical exam (menstrual status, symptom pattern, medication use, family history).
• Common labs (individualized):
  • Women: FSH, estradiol (note: single estradiol levels can be misleading in perimenopause), TSH, CBC, lipids, fasting glucose. Baseline mammogram and pelvic exam as appropriate.
  • Men: two morning total testosterone measurements on separate days (plus free testosterone if needed), SHBG, CBC, PSA (age‑appropriate), lipids, glucose.
• Beware of saliva tests: they are popular in some clinics but are not well validated for guiding therapy in most settings.

Benefits and risks

• Benefits: best therapy for vasomotor symptoms and often improves sleep, mood, sexual function (with appropriate hormones).
• Risks: depends on hormone type/dose/route and your health. Possible increased risk of blood clots, stroke, gallbladder disease, and, with some regimens and durations, possible increased breast cancer risk. Transdermal estradiol and micronized progesterone are thought to have a safer profile for clot risk than oral estrogen and some synthetic progestins, but individual risk varies.
• Compounded BHRT lacks the same regulatory oversight—potency and purity can vary.

Practical steps to take

1. If you have bothersome symptoms, book an appointment with a clinician who manages hormones (menopause specialist, OB/GYN, endocrinologist, or experienced primary care doctor).
2. Bring a symptom list and relevant family history (breast cancer, clotting disorders, heart disease).
3. Get recommended baseline tests and discuss treatment options (nonhormonal and hormonal).
4. If you start therapy, expect follow‑up to reassess symptoms and monitor safety.

Specific product examples (FDA‑approved options I can mention)

• Estradiol patches/gels (transdermal): Vivelle‑Dot, Climara — good for systemic estrogen with lower first‑pass liver effects.
• Oral estradiol: Estrace — commonly used when oral route preferred.
• Micronized progesterone: Prometrium — a bioidentical progesterone available as an FDA product; used to protect the uterus when systemic estrogen is given to women with a uterus.
• Testosterone (men; and sometimes off‑label for women under specialist care): AndroGel, Testim, Aveed, Natesto — require careful monitoring.
• Vaginal/local products for GSM (genitourinary syndrome of menopause): local low‑dose estradiol rings/creams (Estring, vaginal estradiol creams) for vaginal dryness and painful intercourse.
• DHEA for vaginal symptoms (prescription prasterone/Intrarosa in some countries) may be an option for certain women.

When to avoid BHRT (general cautions)

• Active or recent breast cancer (discuss with oncologist), known estrogen‑sensitive cancers, active liver disease, known history of venous thromboembolism or high clot risk, uncontrolled cardiovascular disease—these may preclude hormone therapy or require specialist input.

Alternatives

• Lifestyle measures (cooling techniques, weight loss, exercise), nonhormonal medications for hot flashes (SSRIs/SNRIs such as venlafaxine, other options like gabapentin, clonidine), vaginal moisturizers and lubricants for dryness, psychologic therapies for mood/sleep.

Resources and guidelines

• North American Menopause Society (NAMS) and the Endocrine Society provide evidence‑based guidance on hormone therapy and BHRT. Your clinician can help interpret guidelines for your situation.

Bottom line BHRT can be very effective for hormone‑related symptoms, but it isn’t right for everyone. If you think you might benefit, make an appointment with a provider experienced in menopause or hormone therapy, get recommended tests, and have a shared decision‑making discussion about expected benefits, risks, and monitoring. If you want, tell me your age, sex, and main symptoms and I can suggest what to ask your clinician and which tests are most relevant.